Selective IKur Inhibitors for the Potential Treatment of Atrial Fibrillation: Optimization of the Phenyl Quinazoline Series Leading to Clinical Candidate 5-[5-Phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl]pyridine-3-sulfonamide.
暂无分享,去创建一个
S. Mandlekar | A. Mathur | Abhisek Banerjee | A. Gupta | M. Conder | J. Lloyd | P. Levesque | R. Wexler | Jayakumar S. Warrier | Anuradha Gupta | Ajay Saxena | D. Xing | J. Hennan | H. Finlay | D. Kumaraguru | A. Chimalakonda | R. Rampulla | Ramya Jayaram | James A. Johnson | N. Yadav | Harinath Sale | P. Gunaga | N. Dhondi | S. Putlur | S. Mummadi | Veena Subray | Nagendra Rajugowda | Kommuri Umamaheshwar Reddy | Umasankar Mandal | Dasthagiri Beldona | Ashok Kumar Adisechen